
Metabolic Research
Eloralintide (10mg)
Eloralintide (LY3841136) is a long-acting, selective agonist of the amylin receptor — the pancreatic-hormone pathway that signals fullness, slows gastric emptying and moderates post-meal glucose. It was engineered for once-weekly research dosing and differs from Cagrilintide in its receptor selectivity: where Cagrilintide is a dual amylin and calcitonin receptor agonist (DACRA), Eloralintide is designed to act on the amylin receptor with minimal calcitonin receptor activity.
SKU: PEP-045-10MG





